US 10689717
Methods and compositions for targeted single-stranded cleavage and targeted integration
granted A61KA61K38/00A61P
Quick answer
US patent 10689717 (Methods and compositions for targeted single-stranded cleavage and targeted integration) held by Sangamo Therapeutics, Inc. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12, A61P43/00